The Company has formed a Scientific Advisory Board comprised of some of the key thought leaders in regenerative medicine, vascular biology, and cosmetic medicine.

Stephen Badylak, DVM, MD, PhD
University of Pittsburgh
Tissue experience

Michael Conte, MD
Brigham and Women's
Vascular and Regulatory

Jeffrey Lawson, MD, PhD
Duke University
Vascular Surgeon

Jordan Pober, MD, PhD
Yale University
Immunology/transplantation

Moses Goddard, MD
Univ of RI in Providence
Cytotherapeutics
Vascular and industry

Gail Naughton, PhD
San Diego State Business
ATS CEO
Tissue engineering

Gus Vlahakes, MD
Head of Cardiovascular Surgery at Mass Gen
Cardiovascular